Weight gain and increase in visceral fat have been described in patients with RA receiving TNF-α- and IL-6-inhibitors, but weight gain was not found in a cohort of children with JIA on TNF-α inhibitor therapy compared with JIA patients not treated with TNF-α inhibitors [59]; body composition was, however, not assessed. This evidence concerns the gene TNF and juvenile idiopathic arthritis.